Q: I agree that it is a great business but I would appreciate more details on the valuation metrics you look at to evaluate the company. You mention that it is cheap but I see it at 24 times LTM earnings of 6.57 per share. I find that to be on the high end of it's historical range. Maybe I am missing something here ? Is there a better metric to look at ? Thank you!!
Q: What do you make of the CFO resignation today. How instramental was he in Couche Tarde's recent growth? Do you know how deep their bench is for an internal replacement? I noticed that ATD was Peter's top pick on BNN today. Whoud this recent development concern you?
Q: Hello, I have owned Boston Pizza for about 2 years and while I like the dividend the stock is down about 15%. If you were going to stay in the same sector, would you stick with Boston Pizza or switch those funds to A and W? Thanks for continued great service. Bill
Of the following stocks that I currently own: GXI,CSU,AVO,WSP,IPL and XSR; how would you evaluate their status as to long term holds given the fact that GXI,AVO, and XSR are down approximately 33% - 46% ? What replacements would you otherwise choose?
Q: Hi 5i,
In the tech portion of my portfolio I have:
Apple 3%, Google 3%, Enghouse 1.5%, Cognizant 1.25%, Open Text 1.25%, and Qualcomm 1%.
Would any of the above be a sell in your opinion?
I am considering adding about a 1.5% position in either Kinaxis (kxs) or Tucowsn(tc). For a 2 to 3 year hold, would you recommend one over the other?
And if neither of these stocks are to your liking could you recommend 1 or 2 others to consider.
Thanks for all that you do.
"I just don't like paying for acquisitions that haven't happened yet, and when you pay more than 20x earnings for an otherwise no growth company that is exactly what you are doing. This is why we own Open Text but not Constellation Software. If Open Text doesn't make an acquisition for the next two years it might drop about 10%, putting its valuation on par with Oracle (to name another low growth consolidator); the same scenario played out with the aforementioned Constellation Software would send that stock down over 30%."
CSU's share and earnings growth is largely based on its excellent ability to acquire businesses and less so on on its organic growth. If CSU is unable to acquire companies at the same pace (the larger it gets, the bigger the acquisition required to make an impact), would this not cause a material negative affect on its valuation?
Research report dated Oct. 12 from Bloom Burton (investment bank specializing in Healthcare in the US) regarding CXR. Please note that valuation is in USD in the report. A $78USD target price would imply ~$100CAD.
It appears there is a massive disconnect between CXR's current share price and its earning potential. The selling is become almost ridiculous at this point. Thoughts?
Q: Last 5i comment on EMA appears to be almost two years ago. Could I please have your current thoughts on this utility for income and some growth? Thanks.
Q: Just to clarify the tax treatment re: BPY.UN distributions. I have held the TSX listed BPY.UN, BEP.UN and BIP.UN for a long time in a taxable account and there are no US withholding taxes withheld on the distributions. The distribution is taxed differently than a straight dividend (via the T5013) however. If you held the US listed stocks I think there would be a US withholding tax. Hope this helps.
Q: HI Peter,
I understand that the patient home story was a foolish mistake by the executives, but do you think it deserves a drop from @2 down to 60 cents, especially when the dust has settled? With respect to Nobilus Health, the article from midas letter clearly shows the intent of the Alpha writer but there seems to be no recourse from SEC. In the future, what chance does an average investor have when there are folks trying to manipulate the stock without repercussions. This is not an easy issue, but any comments would be appreciated as it seems the small cap space is just to vulnerable regardless of how well the companies are doing. Also, do you have a link to check shorts on a stock. Lastly, Constellation is on a roll without much news. Any comments. Thanks again.
Q: Could you comment on the Hydro One IPO available now at some brokerages. Do you think the price range is reasonable (very annoying when it is not specified exactly), and do you see any growth in the proposed dividend. Do you think it might be better to just wait and buy on the market, if at all.
Q: 11:31 AM 10/10/2015
Hi Peter:
The article in the Oct 10, 2015 Globe and Mail suggests that the Hydro One IPO will come out very soon with a suggested price range of $19 to $21 per share and with a suggested yield of 4.2%
How would you value Hydro One when compared to other utilities with comparable yields such as Brookfield Infrastructure [5.36%], Algonquin Power [5.33%], Emera [4.35%], Fortis [3.86%]?
Will Hydro One be burdened with debt and, looking ahead, will it need to raise money for ongoing operations?
Would you be buying Hydro One at it's IPO or would you prefer one or more on the other utilities which have proven operating records and strong growth, most with rising earnings and dividends? Which would you buy for regular income?
Q: Could you give your out look on the company's balance sheet (short term/ long term debt and cash) and revenue growth going forward. I am holding this for the upgrade cycle which many analysts think will either start in Q1 or Q2 of 2016 and continue going forward. I see no other alternative if the rail industry still wishes to move crude and dangerous materials through areas of high concern. I see $1.80 as the holding point and if it breaks would you see $1.00? Thank you for your help. Jason